
General Mills' venture capital arm, 301 Inc., focuses on investing in early-stage food companies with remarkable products and strong brands, particularly in areas like plant-based proteins, wellness, and sustainable food systems. It aims to accelerate their growth by providing capital and leveraging General Mills' expertise, though new investments through 301 Inc. have been paused since March 2025.
50% of their portfolio is in Food & Agriculture. Their most common stage is growth (50% of deals). Average disclosed round size is $44.8M (across 4 rounds with reported amounts).
Portfolio
4
Fund Size
—
Top Stage
Growth
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
4 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| FFellos | Growth | $2M | Oct 2025 |
| Series B | $15M | Nov 2024 | |
| Growth | $120M | — | |
| Series B | $42M | — |
Top Co-Investors
Last updated: 28 April 2026